in Newswire October 12, 2018

Class Action Lawsuit Alleges Chinese Companies Sold Valsartan Blood Pressure Medication ‘Adulterated’ with Carcinogen

Gonteski v. Huahai Us, Inc. et al

Filed: October 11, 2018 § 3:18cv14858

Two Chinese companies face a class action over their alleged role in manufacturing and selling adulterated Valsartan, a blood pressure medication.



New Jersey

Last Updated on October 12, 2018 — 2:10 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.